APA

Kreutzman A., Ladell K., Koechel C., Gostick E., Ekblom M., Stenke L., Melo T., Einsele H., Porkka K., Price D. A., Mustjoki S. & Seggewiss R. (20111121). Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. : Leukemia.

Chicago

Kreutzman A, Ladell K, Koechel C, Gostick E, Ekblom M, Stenke L, Melo T, Einsele H, Porkka K, Price D A, Mustjoki S and Seggewiss R. 20111121. Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. : Leukemia.

Harvard

Kreutzman A., Ladell K., Koechel C., Gostick E., Ekblom M., Stenke L., Melo T., Einsele H., Porkka K., Price D. A., Mustjoki S. and Seggewiss R. (20111121). Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. : Leukemia.

MLA

Kreutzman A, Ladell K, Koechel C, Gostick E, Ekblom M, Stenke L, Melo T, Einsele H, Porkka K, Price D A, Mustjoki S and Seggewiss R. Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. : Leukemia. 20111121.